Haisco Secures IND Application Acceptance for Innovative Drug HSK44459 Cream in Two Indications

Stock News

Mar 12

Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) announced that it has recently received a Notice of Acceptance from the National Medical Products Administration for its drug application concerning "HSK44459 Cream." HSK44459 Cream is a novel, independently developed drug with proprietary intellectual property rights for the treatment of psoriasis and atopic dermatitis. Preclinical research results indicate that the drug has a clear target, reliable efficacy, and a favorable safety profile. As a small-molecule drug with significant development potential, it offers a high benefit/risk ratio for clinical application and holds broad prospects for clinical use. It is expected to become an effective treatment for psoriasis and atopic dermatitis, addressing the current shortage of clinical therapeutic options.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1141679135"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1141679135\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1141679135?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-12 16:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141679135","market":"fut","top_or_hot":-1,"title":"Haisco Secures IND Application Acceptance for Innovative Drug HSK44459 Cream in Two Indications","media":"Stock News","content":"<p>Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) announced that it has recently received a Notice of Acceptance from the National Medical Products Administration for its drug application concerning \"HSK44459 Cream.\" HSK44459 Cream is a novel, independently developed drug with proprietary intellectual property rights for the treatment of psoriasis and atopic dermatitis. Preclinical research results indicate that the drug has a clear target, reliable efficacy, and a favorable safety profile. As a small-molecule drug with significant development potential, it offers a high benefit/risk ratio for clinical application and holds broad prospects for clinical use. It is expected to become an effective treatment for psoriasis and atopic dermatitis, addressing the current shortage of clinical therapeutic options.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Haisco Secures IND Application Acceptance for Innovative Drug HSK44459 Cream in Two Indications</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHaisco Secures IND Application Acceptance for Innovative Drug HSK44459 Cream in Two Indications\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-12 16:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) announced that it has recently received a Notice of Acceptance from the National Medical Products Administration for its drug application concerning \"HSK44459 Cream.\" HSK44459 Cream is a novel, independently developed drug with proprietary intellectual property rights for the treatment of psoriasis and atopic dermatitis. Preclinical research results indicate that the drug has a clear target, reliable efficacy, and a favorable safety profile. As a small-molecule drug with significant development potential, it offers a high benefit/risk ratio for clinical application and holds broad prospects for clinical use. It is expected to become an effective treatment for psoriasis and atopic dermatitis, addressing the current shortage of clinical therapeutic options.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1574","symbol_name":"生物医药B类股","start_time":0,"source_url":"","article_id":"1141679135","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141679135","pubTimestamp":1773302750,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) announced that it has recently received a Notice of Acceptance from the National Medical Products Administration for its drug application concerning...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159992":"创新药","BK1574":"生物医药B类股","IND":"Xtrackers Nifty 500 India ETF","BK0033":"西藏振兴","BK0077":"质押式回购","BK0028":"国家队","BK0239":"医药制造","002653":"海思科","BK0188":"融资融券","06978":"永泰生物-B","BK1161":"生物科技"},"translate_title":"海思科确保创新药HSK44459乳膏两个适应症IND申请受理","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1,"06978":1,"IND":1,"002653":1},"content_text":"Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) announced that it has recently received a Notice of Acceptance from the National Medical Products Administration for its drug application concerning \"HSK44459 Cream.\" HSK44459 Cream is a novel, independently developed drug with proprietary intellectual property rights for the treatment of psoriasis and atopic dermatitis. Preclinical research results indicate that the drug has a clear target, reliable efficacy, and a favorable safety profile. As a small-molecule drug with significant development potential, it offers a high benefit/risk ratio for clinical application and holds broad prospects for clinical use. It is expected to become an effective treatment for psoriasis and atopic dermatitis, addressing the current shortage of clinical therapeutic options.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}